Acta naturae 2013-04-01

Identification of Novel IGF1R Kinase Inhibitors by Molecular Modeling and High-Throughput Screening.

R Moriev, O Vasylchenko, M Platonov, O Grygorenko, K Volkova, S Zozulya

Index: Acta Naturae 5(2) , 90-9, (2013)

Full Text: HTML

Abstract

The aim of this study was to identify small molecule compounds that inhibit the kinase activity of the IGF1 receptor and represent novel chemical scaffolds, which can be potentially exploited to develop drug candidates that are superior to the existing experimental anti-IGF1R therapeuticals. To this end, targeted compound libraries were produced by virtual screening using molecular modeling and docking strategies, as well as the ligand-based pharmacophore model. High-throughput screening of the resulting compound sets in a biochemical kinase inhibition assay allowed us to identify several novel chemotypes that represent attractive starting points for the development of advanced IGF1R inhibitory compounds.


Related Compounds

Related Articles:

IGFBP-2 directly stimulates osteoblast differentiation.

2014-11-01

[J. Bone Miner Res. 29(11) , 2427-38, (2014)]

Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth.

2006-04-01

[Mol. Cancer Ther. 5 , 1079-1086, (2006)]

Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST.

2016-03-01

[J. Pathol. 238 , 543-9, (2016)]

PQ401, an IGF-1R inhibitor, induces apoptosis and inhibits growth, proliferation and migration of glioma cells.

2016-01-01

[J. Chemother. 28 , 44-9, (2016)]

Reduced expression of EI24 confers resistance to gefitinib through IGF-1R signaling in PC9 NSCLC cells.

2015-11-01

[Lung Cancer 90 , 175-81, (2015)]

More Articles...